Sanofi : Disclosure of trading in own shares

January 23, 2017 12:37 ET | Source: Sanofi Winthrop Industrie Sanofi Winthrop Industrie

Attachments

Reporting EN...

Recommended Reading

August 14, 2025 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease

Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at...
Read More
August 06, 2025 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

Sanofi completes the acquisition of Vigil Neuroscience, Inc. Paris, August 6, 2025. Sanofi announces the completion of its acquisition of Vigil Neuroscience, Inc. (“Vigil”). This acquisition...
Read More